Julie Xie

Dr. Xie brings in proven scientific leadership and extensive experience in drug discovery and development. Prior to Regor, Dr. Xie worked at Pfizer R&D for more than 17 years. She demonstrated strong leadership in delivering oncology projects of novel targets with broad range of mechanisms from kinase signaling, epigenetics, metabolism and immuno-oncology. She led multi-disciplinary teams in advancing projects from exploratory target validation to IND-readiness and was instrumental in developing early clinical development strategy. Dr. Xie has extensive experience in alliance collaboration. She led collaborations with academic institutes and CROs to build early target portfolio and advance pipeline projects. She conducted due diligence of preclinical and clinical oncology assets. Dr. Xie earned her bachelor’s degree in Biochemistry from Wuhan University and Ph.D. in Biochemistry from University of Iowa. She completed her postdoctoral training in HHMI at Vanderbilt University. She is now the head of the Oncology and Immunology Biology group at Regor.